The revised timeline secures Ola Electric a five-year PLI window through 2031 and could unlock up to Rs 7,240 crore in cumulative incentives, the company said in an exchange filing on Wednesday. The ...

For this week's PV Chart of the Week from PV Tech Research we look at the technology breakdown of projected US solar cell production capacity ...

Tesla has submitted plans for a $10.1 billion vertically integrated solar cell manufacturing campus in Fort Bend County under the internal name Project Crystal Sun, seeking property tax limitations ...

HEFEI, ANHUI, CHINA, January 19, 2026 /EINPresswire.com/ — The global photovoltaic (PV) industry is entering a phase defined less by headline capacity additions and ...

Canadian Solar said it has opened the first phase of its flagship PV cell manufacturing facility at the River Ridge Commerce Center in Jeffersonville, Indiana.

At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

Legend Biotech (NASDAQ:LEGN) reports today. Explore the key operating questions around cell-therapy demand and manufacturing, ...

In just a year, ALMM-listed solar PV cell manufacturing capacity has increased from around 13 GW to roughly 31 GW across eight revisions. With a substantial pipeline of commissioned, ...

While Kite Pharma has partnered with Cytiva to develop a new cell therapy manufacturing platform, which was rolled out last month, the Gilead Sciences subsidiary isn’t stopping there in its pursuit of ...

The clinical pipeline for cell and gene therapies is expanding rapidly, but a significant gap remains between preclinical success and regulatory approval. Very few of these advanced therapies reach ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...